Fehlende Medikamente zur Bekämpfung armutsassoziierter Krankheiten sind ein globales Gesundheitsproblem.Katrin Gerlinger stellt in diesem Band Initiativen öffentlicher, gemeinnütziger und privater Akteure zur Stärkung der Produktentwicklung vor und nennt politische Optionen zur Förderung...

This study conducted an experiment in Mali to test whether patients pressure doctors to prescribe medical treatment they do not necessarily need. The experiment varied patients' information about a discount for antimalarial tablets and measured demand for both tablets and costlier antimalarial...

Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one run the risk of increasing the other. Using rich experimental data on household treatment-seeking behavior in Kenya, we study the implications of this tradeoff for subsidizing life-saving...

Many new Product Development Partnerships (PDPs) have recently been formed with the sole objective of developing drugs for neglected diseases with a high prevalence in the developing world. The Medicines for Malaria Venture (MMV) is a PDP that was established in 1999 to develop new drugs for...

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently approved an innovative initiative called the Affordable Medicines Facility for malaria (AMFm), to increase access to artemisinin-based combination therapies (ACTs) for the treatment of malaria. The AMFm emerged from proposals in...